Abstract:Genetic variation in the lysosomal and transmembrane protein 106B (TMEM106B) modifies risk for a diverse range of neurodegenerative disorders, especially frontotemporal lobar degeneration (FTLD) with progranulin (PGRN) haplo-insufficiency, although the molecular mechanisms involved are not yet understood. Through advances in cryo-electron microscopy (cryo-EM), homotypic aggregates of the C-Terminal domain of TMEM106B (TMEM CT) were discovered as a previously unidentified cytosolic proteinopathy in the brains of FTLD, Alzheimers disease, progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB) patients. While it remains unknown what role TMEM CT aggregation plays in neuronal loss, its presence across a range of aging related dementia disorders indicates involvement in multi-proteinopathy driven neurodegeneration. To determine the TMEM CT aggregation propensity and neurodegenerative potential, we characterized a novel transgenic C. elegans model expressing the human TMEM CT fragment constituting the fibrillar core seen in FTLD cases. We found that pan-neuronal expression of human TMEM CT in C. elegans causes neuronal dysfunction as evidenced by behavioral analysis. Cytosolic aggregation of TMEM CT proteins accompanied the behavioral dysfunction driving neurodegeneration, as illustrated by loss of GABAergic neurons. To investigate the molecular mechanisms driving TMEM106B proteinopathy, we explored the impact of PGRN loss on the neurodegenerative effect of TMEM CT expression. To this end, we generated TMEM CT expressing C. elegans with loss of pgrn-1, the C. elegans ortholog of human PGRN. Neither full nor partial loss of pgrn-1 altered the motor phenotype of our TMEM CT model suggesting TMEM CT aggregation occurs downstream of PGRN loss of function. We also tested the ability of genetic suppressors of tauopathy to rescue TMEM CT pathology. We found that genetic knockout of spop-1, sut-2, and sut-6 resulted in weak to no rescue of proteinopathy phenotypes, indicating that the mechanistic drivers of TMEM106B proteinopathy may be distinct from tauopathy. Taken together, our data demonstrate that TMEM CT aggregation can kill neurons. Further, expression of TMEM CT in C. elegans neurons provides a useful model for the functional characterization of TMEM106B proteinopathy in neurodegenerative disease.

Neural-specific distribution of transmembrane protein TMEM240 and formation of TMEM240-Body

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

The TMEM240 Protein, Mutated in SCA21, Is Expressed in Purkinje Cells and Synaptic Terminals

TMEM63 mechanosensitive ion channels: Activation mechanisms, biological functions and human genetic disorders

The Neuron-Specific Protein TMEM59L Mediates Oxidative Stress-Induced Cell Death.

Mechanism Underlying the Brain-specific Membrane-anchored Protein TMEM59L-mediated Apoptosis

TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy.

Divergent and Convergent TMEM106B Pathology in Murine Models of Neurodegeneration and Human Disease

Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function

Physiological and pathological functions of TMEM106B in neurodegenerative diseases

A splicing-dependent ER retention signal regulates surface expression of the mechanosensitive TMEM63B cation channel

TMEM25 Modulates Neuronal Excitability and NMDA Receptor Subunit NR2B Degradation.

Studies on Expression and Function of the TMEM16A Calcium-Activated Chloride Channel.

Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging

Disruption of Tmem30a Results in Cerebellar Ataxia and Degeneration of Purkinje Cells

Transmembrane Protein 230 Mediates a Poly(ADP-ribose) Polymerase-1-Linked Apoptosis

Transmembrane Protein 214 (TMEM214) Mediates Endoplasmic Reticulum Stress-induced Caspase 4 Enzyme Activation and Apoptosis

Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains.

Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome via alteration of metabolic signaling

TMEM43-S358L Mutation Enhances NF-κBTGFβ Signal Cascade in Arrhythmogenic Right Ventricular Dysplasia/cardiomyopathy